Eric Paul Hohenschuh

Title: Innovations of Eric Paul Hohenschuh

Introduction

Eric Paul Hohenschuh is an accomplished inventor based in Berwyn, Pennsylvania. He holds two patents that showcase his contributions to the field of medical technology. His work primarily focuses on sonodynamic therapy and imaging contrast agents.

Latest Patents

One of Hohenschuh's latest patents is titled "Sonodynamic therapy using an ultrasound sensitizer compound." This invention describes a method of treating a human or animal body by administering a sensitizer agent and exposing the body to ultrasound. The goal is to achieve a cytopathogenic effect at a specific site within the body. The sensitizer agent is a physiologically tolerable substance that enhances the efficacy of sonodynamic therapy. Preferably, this agent is a water-soluble polymer compound or a conjugate thereof.

Another significant patent is related to "Compounds," which provides a physiologically tolerable light imaging contrast agent. This compound has a molecular weight ranging from 500 to 5,000,000 and contains at least two chromophores with delocalized electron systems. Additionally, it includes at least one polyalkylene oxide (PAO) moiety with a molecular weight between 60 and 100,000.

Career Highlights

Throughout his career, Hohenschuh has worked with notable companies such as Nycomed Imaging and Amersham Health. His experience in these organizations has contributed to his expertise in medical imaging and therapeutic technologies.

Collaborations

Hohenschuh has collaborated with several professionals in his field, including Robert A. Snow and Paul Mark Henrichs. These collaborations have likely enriched his work and led to innovative advancements in his projects.

Conclusion

Eric Paul Hohenschuh's contributions to medical technology through his patents reflect his dedication to innovation. His work in sonodynamic therapy and imaging contrast agents demonstrates the potential for advancements in treatment methodologies.